Literature DB >> 11297527

5-Lipoxygenase interacts with coactosin-like protein.

P Provost1, J Doucet, T Hammarberg, G Gerisch, B Samuelsson, O Radmark.   

Abstract

We have recently identified coactosin-like protein (CLP) in a yeast two-hybrid screen using 5-lipoxygenase (5LO) as a bait. In this report, we demonstrate a direct interaction between 5LO and CLP. 5LO associated with CLP, which was expressed as a glutathione S-transferase fusion protein, in a dose-dependent manner. Coimmunoprecipitation experiments using epitope-tagged 5LO and CLP proteins transiently expressed in human embryonic kidney 293 cells revealed the presence of CLP in 5LO immunoprecipitates. In reciprocal experiments, 5LO was detected in CLP immunoprecipitates. Non-denaturing polyacrylamide gel electrophoresis and cross-linking experiments showed that 5LO binds CLP in a 1:1 molar stoichiometry in a Ca(2+)-independent manner. Site-directed mutagenesis suggested an important role for lysine 131 of CLP in mediating 5LO binding. In view of the ability of CLP to bind 5LO and filamentous actin (F-actin), we determined whether CLP could physically link 5LO to actin filaments. However, no F-actin-CLP.5LO ternary complex was observed. In contrast, 5LO appeared to compete with F-actin for the binding of CLP. Moreover, 5LO was found to interfere with actin polymerization. Our results indicate that the 5LO-CLP and CLP-F-actin interactions are mutually exclusive and suggest a modulatory role for 5LO in actin dynamics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297527     DOI: 10.1074/jbc.M011205200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  NMR structure of human coactosin-like protein.

Authors:  Edvards Liepinsh; Marija Rakonjac; Vincent Boissonneault; Patrick Provost; Bengt Samuelsson; Olof Rådmark; Gottfried Otting
Journal:  J Biomol NMR       Date:  2004-11       Impact factor: 2.835

2.  Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease.

Authors:  Milos D Ikonomovic; Eric E Abrahamson; Tolga Uz; Hari Manev; Steven T Dekosky
Journal:  J Histochem Cytochem       Date:  2008-08-04       Impact factor: 2.479

3.  Ribonuclease activity and RNA binding of recombinant human Dicer.

Authors:  Patrick Provost; David Dishart; Johanne Doucet; David Frendewey; Bengt Samuelsson; Olof Rådmark
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

Review 4.  Actin filaments-A target for redox regulation.

Authors:  Carlos Wilson; Jonathan R Terman; Christian González-Billault; Giasuddin Ahmed
Journal:  Cytoskeleton (Hoboken)       Date:  2016-08-06

5.  A genomewide overexpression screen identifies genes involved in the phosphatidylinositol 3-kinase pathway in the human protozoan parasite Entamoeba histolytica.

Authors:  Amrita B Koushik; Brenda H Welter; Michelle L Rock; Lesly A Temesvari
Journal:  Eukaryot Cell       Date:  2014-01-17

6.  5-Lipoxygenase: mechanisms of regulation.

Authors:  Olof Rådmark; Bengt Samuelsson
Journal:  J Lipid Res       Date:  2008-11-05       Impact factor: 5.922

7.  15-lipoxygenase-1 activates tumor suppressor p53 independent of enzymatic activity.

Authors:  Hong Zhu; Wayne Glasgow; Margaret D George; Kali Chrysovergis; Kenneth Olden; John D Roberts; Thomas Eling
Journal:  Int J Cancer       Date:  2008-12-15       Impact factor: 7.396

8.  Molecular pharmacological profile of the nonredox-type 5-lipoxygenase inhibitor CJ-13,610.

Authors:  Lutz Fischer; Dieter Steinhilber; Oliver Werz
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

9.  Crystal structure of human coactosin-like protein at 1.9 A resolution.

Authors:  Xuemei Li; Xueqi Liu; Zhiyong Lou; Xin Duan; Hao Wu; Yiwei Liu; Zihe Rao
Journal:  Protein Sci       Date:  2004-09-30       Impact factor: 6.725

10.  Hyperforin is a novel type of 5-lipoxygenase inhibitor with high efficacy in vivo.

Authors:  Christian Feisst; Carlo Pergola; Marija Rakonjac; Antonietta Rossi; Andreas Koeberle; Gabriele Dodt; Marika Hoffmann; Christina Hoernig; Lutz Fischer; Dieter Steinhilber; Lutz Franke; Gisbert Schneider; Olof Rådmark; Lidia Sautebin; Oliver Werz
Journal:  Cell Mol Life Sci       Date:  2009-07-05       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.